/content/mofsl-website-adobe/fragments/open-demat-popup
style
hide-in-desktop

Mediwound Ltd Share Price Today: Live Updates & Key Insights

Mediwound Ltd share price today is $17.29, up -0.06%. The stock opened at $17.255 against the previous close of $16.97, with an intraday high of $17.255 and low of $16.75.

Mediwound Ltd Share Price Chart

style
pb-0

Mediwound Ltd

us-stock
To Invest in {{usstockname}}
/content/mofsl-website-adobe/demat-form-fields
style
sticky-block,pt-0
us-stock
style
pt-0

Mediwound Ltd Share Price Performance

$17.29 -0.0006(-0.06%) MDWD at 23 Mar 2026 02:14 PM Biotechnology
Lowest Today 16.75
Highest Today 17.255
Today’s Open 17.255
Prev. Close 16.97
52 Week High 22.51
52 Week Low 14.14
Day’s Range: Low 16.75 High 17.255
52-Week Range: Low 14.14 High 22.51
1 day return -
1 Week return -2.77
1 month return -7.47
3 month return -10.28
6 month return -5.86
1 year return +2.24
3 year return +46.18
5 year return -57.79
10 year return -

Mediwound Ltd Institutional Holdings

Investors Finance Co PLC 6.79

Yelin Lapidot Holdings Management Ltd 5.95

Rosalind Advisors, Inc. 5.84

T. Rowe Price Associates, Inc. 4.79

BlackRock Inc 3.15

Meitav Dash Investments Ltd 2.90

T. Rowe Price New Horizons 1.92

US Small-Cap Growth II Equity Comp 1.88

Sphera Funds Management Ltd. 1.79

iShares Russell 2000 ETF 1.64

Silverberg Bernstein Capital Management LLC 1.43

T. Rowe Price Integrated US Sm Gr Eq 1.22

T. Rowe Price Health Sciences 1.04

ARK Israel Innovative Technology ETF 1.01

Geode Capital Management, LLC 0.94

Northern Trust Corp 0.90

Dafna Capital Management LLC 0.89

State Street Corp 0.88

ARK Investment Management LLC 0.83

Millennium Management LLC 0.80

Fidelity Small Cap Index 0.75

Citadel Advisors Llc 0.70

T. Rowe Price New Horizons Tr-A 0.68

UBS Group AG 0.59

iShares Russell 2000 Growth ETF 0.57

Clal Insurance Enterprises Holdings Ltd 0.55

Vanguard Group Inc 0.51

MENORA MIVTACHIM HOLDINGS LIMITED 0.51

Point72 Asset Management, L.P. 0.48

SSgA Russell Small Cap Completeness Idx 0.40

State St Russell Sm/Mid Cp® Indx SL Cl I 0.40

Vanguard Russell 2000 ETF 0.36

iShares Micro-Cap ETF 0.20

TD Health Sciences - I 0.19

Schwab Small Cap Index 0.19

T. Rowe Price Integrated US SMCC Eq I 0.17

NT R2000 Index Fund - NL 0.16

NT R2000 Index Fund - DC - NL - 3 0.13

State St Russell Sm Cap® Indx SL Cl I 0.11

iShares Russell 2000 Small-Cap Idx Instl 0.10

Mediwound Ltd Market Status

Strong Buy: 4

Buy: 2

Hold: 0

Sell: 0

Strong Sell: 0

Mediwound Ltd Fundamentals

Market Cap 217.86 M

PB Ratio 4.9873

PE Ratio 0.0

Enterprise Value 172.62 M

Total Assets 86.26 M

Volume 82317

Mediwound Ltd Company Financials

Annual Revenue FY23:24966000 25.0M, FY22:26496000 26.5M, FY21:23763000 23.8M, FY20:21763000 21.8M, FY19:31789000 31.8M

Annual Profit FY23:11017000 11.0M, FY22:13165000 13.2M, FY21:8771000 8.8M, FY20:7545000 7.5M, FY19:19940000 19.9M

Annual Net worth FY23:-12430000 -12.4M, FY22:-19599000 -19.6M, FY21:-13551000 -13.6M, FY20:-9601000 -9.6M, FY19:3718000 3.7M

Quarterly Revenue Q3/2025:5429000 5.4M, Q2/2025:5708000 5.7M, Q1/2025:3955000 4.0M, Q3/2024:4355000 4.4M, Q2/2024:5063000 5.1M

Quarterly Profit Q3/2025:896000 0.9M, Q2/2025:1342000 1.3M, Q1/2025:738000 0.7M, Q3/2024:677000 0.7M, Q2/2024:447000 0.4M

Quarterly Net worth Q3/2025:-2652000 -2.7M, Q2/2025:-13318000 -13.3M, Q1/2025:-726000 -0.7M, Q3/2024:-10282000 -10.3M, Q2/2024:-6305000 -6.3M

About Mediwound Ltd & investment objective

Company Information MediWound Ltd., a biopharmaceutical company, develops, manufactures, and commercializes novel, bio-therapeutic, and non-surgical solutions for tissue repair and regeneration in the United States, Germany, Italy, Spain, and internationally. The company markets NexoBrid, a biopharmaceutical product for the removal of eschar in patients with deep partial- and full-thickness thermal burns to burn centers and hospitals burn units. It also develops EscharEx, a bromelain-based, bioactive enzymatic therapy for the treatment of chronic wounds and other hard-to-heal wounds; and MW005, a topically applied biological product candidate to treat non-melanoma skin cancers. MediWound Ltd. was incorporated in 2000 and is headquartered in Yavne, Israel.

Organisation Biotechnology

Employees 121

Industry Biotechnology

CEO null

Trading and brokerage services provided by

Technology Services provided by Motilal Oswal Financial Services:

Disclaimer: These services are not for exchange traded products. The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Motilal Oswal Financial Services acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*

Take your next step

Talk to our investment advisor for stock recommendations
Left
Get expert assistance for portfolio management
Right
style
align-center,button-arrow

Mediwound Ltd FAQs

What is the share price of Mediwound Ltd today?

The current share price of Mediwound Ltd is $17.29.

Can I buy Mediwound Ltd shares in India?

Yes, Indian investors can buy Mediwound Ltd shares by opening an international trading and demat account with Motilal Oswal.

How to buy Mediwound Ltd shares in India?

You can easily invest in Mediwound Ltd shares from India by:

Can I buy fractional shares of Mediwound Ltd?

Yes, many platforms allow you to buy fractional shares starting from as low as $1.

What is the market capitalization value of Mediwound Ltd?

Mediwound Ltd has a market cap of $217.86 M.

In which sector does Mediwound Ltd belong?

Mediwound Ltd operates in the Biotechnology sector.

What documents are required to invest in Mediwound Ltd stocks?

To invest, you typically need:

What is the PE and PB ratio of Mediwound Ltd?

The PE ratio of Mediwound Ltd is N/A and the PB ratio is 4.99.